DK3350162T3 - Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation - Google Patents
Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation Download PDFInfo
- Publication number
- DK3350162T3 DK3350162T3 DK16766010.9T DK16766010T DK3350162T3 DK 3350162 T3 DK3350162 T3 DK 3350162T3 DK 16766010 T DK16766010 T DK 16766010T DK 3350162 T3 DK3350162 T3 DK 3350162T3
- Authority
- DK
- Denmark
- Prior art keywords
- disubstituted
- mono
- dengue virus
- virus replication
- inhibit dengue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15185523 | 2015-09-16 | ||
| EP16163472 | 2016-04-01 | ||
| PCT/EP2016/071845 WO2017046255A1 (en) | 2015-09-16 | 2016-09-15 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3350162T3 true DK3350162T3 (da) | 2021-10-04 |
Family
ID=56926217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16766010.9T DK3350162T3 (da) | 2015-09-16 | 2016-09-15 | Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US10765662B2 (da) |
| EP (1) | EP3350162B1 (da) |
| JP (2) | JP7050666B2 (da) |
| KR (1) | KR102646174B1 (da) |
| CN (1) | CN108473422B (da) |
| AU (1) | AU2016324982B2 (da) |
| CA (1) | CA2996979C (da) |
| CL (1) | CL2018000696A1 (da) |
| CO (1) | CO2018003471A2 (da) |
| CR (1) | CR20180213A (da) |
| DK (1) | DK3350162T3 (da) |
| EA (1) | EA035663B1 (da) |
| EC (1) | ECSP18020055A (da) |
| ES (1) | ES2893298T3 (da) |
| HK (1) | HK1257842A1 (da) |
| HR (1) | HRP20211352T1 (da) |
| HU (1) | HUE055870T2 (da) |
| IL (1) | IL258043B (da) |
| JO (1) | JOP20160198B1 (da) |
| LT (1) | LT3350162T (da) |
| MA (1) | MA42810A (da) |
| MX (1) | MX2018003255A (da) |
| NI (1) | NI201800039A (da) |
| PE (1) | PE20181165A1 (da) |
| PH (1) | PH12018500576A1 (da) |
| SI (1) | SI3350162T1 (da) |
| TW (1) | TWI758255B (da) |
| UA (1) | UA122973C2 (da) |
| UY (1) | UY36903A (da) |
| WO (1) | WO2017046255A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| GB201305376D0 (en) | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JO3633B1 (ar) * | 2015-09-16 | 2020-08-27 | Katholieke Univ Leuven Ku Leuven Research & Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CN114716381A (zh) | 2015-12-16 | 2022-07-08 | 洛克索肿瘤学股份有限公司 | 可用作激酶抑制剂的化合物 |
| KR102359735B1 (ko) | 2016-03-31 | 2022-02-08 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 치환 인돌린 유도체 |
| US10646469B2 (en) | 2016-03-31 | 2020-05-12 | Janssen Pharmaceuticals, Inc. | Substituted indole derivatives as dengue viral replication inhibitors |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| EP3436004A1 (en) | 2016-04-01 | 2019-02-06 | Janssen Pharmaceuticals, Inc. | Substituted indole compound derivatives as dengue viral replication inhibitors |
| JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180026A1 (ar) * | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| TWI771420B (zh) * | 2017-05-22 | 2022-07-21 | 美商健生醫藥公司 | 作為登革熱病毒複製抑制劑之經取代之吲哚啉衍生物（一） |
| JP7203764B2 (ja) | 2017-05-22 | 2023-01-13 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | デングウイルス複製阻害剤としての置換インドリン誘導体 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69830335T2 (de) * | 1997-10-27 | 2006-02-02 | Eli Lilly And Co., Indianapolis | MORPHOLINO-N-ETHYL ESTER PRODROGEN VON INDOL sPLA 2 HEMMER |
| GB0110832D0 (en) | 2001-05-03 | 2001-06-27 | Virogen Ltd | Antiviral compounds |
| WO2003050295A2 (en) | 2001-12-12 | 2003-06-19 | Conforma Therapeutics Corporation | Assays and implements for determining and modulating hsp90 binding activity |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| MX2007008587A (es) | 2005-01-14 | 2007-09-07 | Genelabs Tech Inc | Derivados de indol para tratamiento de infecciones virales. |
| KR20070102741A (ko) | 2005-02-09 | 2007-10-19 | 미게닉스 인코포레이티드 | 플라비비리대 감염증을 치료하거나 예방하기 위한 조성물및 방법 |
| PE20081897A1 (es) * | 2007-03-29 | 2009-02-09 | Novartis Ag | 3-imidazolil-indoles para el tratamiento de enfermedades proliferativas |
| FR2928645A1 (fr) * | 2008-03-14 | 2009-09-18 | Sanofi Aventis Sa | Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation |
| EP2293671A4 (en) | 2008-06-03 | 2012-03-21 | Siga Technologies Inc | SMALL MOLECULAR INHIBITORS FOR TREATING OR PREVENTING DENGUE INFECTIONS |
| EA201170349A1 (ru) * | 2008-08-18 | 2011-08-30 | Йейл Юниверсити | Модуляторы mif |
| US8143259B2 (en) | 2008-08-19 | 2012-03-27 | Janssen Pharmaceutica, Nv | Cold menthol receptor antagonists |
| TWI453207B (zh) | 2008-09-08 | 2014-09-21 | Signal Pharm Llc | 胺基三唑并吡啶，其組合物及使用其之治療方法 |
| GB0910003D0 (en) | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| US8993604B2 (en) | 2009-06-30 | 2015-03-31 | Siga Technologies, Inc. | Treatment and prevention of dengue virus infections |
| ES2543105T3 (es) | 2010-01-15 | 2015-08-14 | Gilead Sciences, Inc. | Inhibidores de virus flaviviridae |
| WO2011120025A1 (en) * | 2010-03-26 | 2011-09-29 | Glaxo Group Limited | Indazolyl-pyrimidines as kinase inhibitors |
| GB201116559D0 (en) * | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| GB201305376D0 (en) * | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
| AP2016009122A0 (en) | 2013-10-23 | 2016-03-31 | Janssen Sciences Ireland Uc | Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |
| DK3099687T3 (da) | 2014-01-31 | 2018-10-22 | Bristol Myers Squibb Co | Makrocykler med heterocykliske p2'-grupper som faktor xia-hæmmere |
| NO2721243T3 (da) | 2014-10-01 | 2018-10-20 | ||
| UA121119C2 (uk) | 2014-10-01 | 2020-04-10 | Янссен Фармасьютикалз, Інк. | Похідні моно- або дизаміщених індолів як інгібітори реплікації вірусів денге |
| JP6701185B2 (ja) * | 2014-10-01 | 2020-05-27 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | デングウィルス複製阻害剤としての一または二置換インドール |
| JOP20150335B1 (ar) | 2015-01-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| AR103680A1 (es) | 2015-02-23 | 2017-05-24 | Lilly Co Eli | Inhibidores selectivos de bace1 |
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JO3633B1 (ar) | 2015-09-16 | 2020-08-27 | Katholieke Univ Leuven Ku Leuven Research & Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| MX2018005547A (es) | 2015-11-03 | 2018-11-09 | Zoetis Services Llc | Compuestos polimericos sol-gel y sus usos. |
| US10646469B2 (en) | 2016-03-31 | 2020-05-12 | Janssen Pharmaceuticals, Inc. | Substituted indole derivatives as dengue viral replication inhibitors |
| CA3019298C (en) | 2016-03-31 | 2023-08-29 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| KR102359735B1 (ko) | 2016-03-31 | 2022-02-08 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 치환 인돌린 유도체 |
| AU2017240667C1 (en) | 2016-04-01 | 2022-11-24 | Kite Pharma, Inc. | Chimeric antigen and T cell receptors and methods of use |
| KR102411744B1 (ko) | 2016-04-01 | 2022-06-21 | 바스프 에스이 | 바이시클릭 화합물 |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CA3019655A1 (en) | 2016-04-01 | 2017-10-05 | Amgen Inc. | Chimeric receptors to flt3 and methods of use thereof |
| EP3436004A1 (en) | 2016-04-01 | 2019-02-06 | Janssen Pharmaceuticals, Inc. | Substituted indole compound derivatives as dengue viral replication inhibitors |
| EP3436018A4 (en) | 2016-04-01 | 2019-11-13 | Signal Pharmaceuticals, LLC | SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS AND METHOD FOR TREATING THEREOF |
| MX2018012019A (es) | 2016-04-01 | 2019-07-10 | Kite Pharma Inc | Receptores quimericos y metodos de uso de los mismos. |
| JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| TWI771420B (zh) | 2017-05-22 | 2022-07-21 | 美商健生醫藥公司 | 作為登革熱病毒複製抑制劑之經取代之吲哚啉衍生物（一） |
| JP7203764B2 (ja) | 2017-05-22 | 2023-01-13 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | デングウイルス複製阻害剤としての置換インドリン誘導体 |
-
2016
- 2016-09-06 JO JOP/2016/0198A patent/JOP20160198B1/ar active
- 2016-09-13 TW TW105129689A patent/TWI758255B/zh active
- 2016-09-15 UA UAA201804007A patent/UA122973C2/uk unknown
- 2016-09-15 WO PCT/EP2016/071845 patent/WO2017046255A1/en active Application Filing
- 2016-09-15 CA CA2996979A patent/CA2996979C/en active Active
- 2016-09-15 MA MA042810A patent/MA42810A/fr unknown
- 2016-09-15 DK DK16766010.9T patent/DK3350162T3/da active
- 2016-09-15 PE PE2018000399A patent/PE20181165A1/es unknown
- 2016-09-15 JP JP2018513474A patent/JP7050666B2/ja active Active
- 2016-09-15 CR CR20180213A patent/CR20180213A/es unknown
- 2016-09-15 ES ES16766010T patent/ES2893298T3/es active Active
- 2016-09-15 US US15/759,846 patent/US10765662B2/en active Active
- 2016-09-15 EA EA201890722A patent/EA035663B1/ru not_active IP Right Cessation
- 2016-09-15 HR HRP20211352TT patent/HRP20211352T1/hr unknown
- 2016-09-15 MX MX2018003255A patent/MX2018003255A/es unknown
- 2016-09-15 HU HUE16766010A patent/HUE055870T2/hu unknown
- 2016-09-15 LT LTEPPCT/EP2016/071845T patent/LT3350162T/lt unknown
- 2016-09-15 KR KR1020187009763A patent/KR102646174B1/ko active IP Right Grant
- 2016-09-15 AU AU2016324982A patent/AU2016324982B2/en active Active
- 2016-09-15 CN CN201680053616.2A patent/CN108473422B/zh active Active
- 2016-09-15 EP EP16766010.9A patent/EP3350162B1/en active Active
- 2016-09-15 SI SI201631355T patent/SI3350162T1/sl unknown
- 2016-09-16 UY UY0001036903A patent/UY36903A/es not_active Application Discontinuation
-
2018
- 2018-03-12 IL IL258043A patent/IL258043B/en unknown
- 2018-03-14 EC ECIEPI201820055A patent/ECSP18020055A/es unknown
- 2018-03-15 NI NI201800039A patent/NI201800039A/es unknown
- 2018-03-15 CL CL2018000696A patent/CL2018000696A1/es unknown
- 2018-03-15 PH PH12018500576A patent/PH12018500576A1/en unknown
- 2018-03-28 CO CONC2018/0003471A patent/CO2018003471A2/es unknown
-
2019
- 2019-01-07 HK HK19100198.9A patent/HK1257842A1/zh unknown
-
2021
- 2021-08-12 JP JP2021131751A patent/JP2021181485A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3350162T3 (da) | Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation | |
| DK3601266T3 (da) | Substituerede indolinderivater som hæmmere af dengue-virusreplikation | |
| DK3229810T3 (da) | Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler | |
| DK3436437T3 (da) | Substituerede indolinderivativer som dengue¬virus-replikations¬hæmmere | |
| DK3461821T3 (da) | Indolcarboxamidforbindelser, der er brugbar som kinasehæmmere | |
| DK3294738T3 (da) | Mono- og disubstituerede indolderivater som inhibitorer af replikation af denguevirus | |
| DK3244886T3 (da) | Indolderivater som inhibitorer af dengue virus-replikation | |
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| DK3297605T3 (da) | Topiske, farmaceutiske sammesætninger | |
| DK3350163T3 (da) | Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation | |
| BR112016023628A2 (pt) | composições farmacêuticas. | |
| FI20155101A (fi) | Nanofibrillaarinen selluloosakoostumus | |
| DK3253762T3 (da) | 9h-pyrrolo-dipyridinderivater. | |
| DK3377483T3 (da) | N-substituerede indolderivater som pge2-receptormodulatorer | |
| DK3363428T3 (da) | Perfusionsdoseringsform | |
| DK3241878T4 (da) | Sammensætning, der omfatter hfc og hfo | |
| DK3347360T3 (da) | Forbindelser, som er anvendelige til inhibering af ror-gamma-t | |
| DK3383397T3 (da) | Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin | |
| DK3389633T3 (da) | Farmaceutiske sammensætninger, der omfatter phenylaminopyrimidinderivat | |
| DK3250550T3 (da) | Sammensætninger og fremgangsmåder til virussensibilisering | |
| DK3417294T3 (da) | Fremgangsmåder, som omfatter fast intermitterende dosering af cediranib | |
| DK3290023T3 (da) | Farmaceutisk sammensætning med langvarig frigivelse, som indeholder rivastigmin | |
| DK3371324T3 (da) | Virusbiomarkører og anvendelser deraf | |
| DK3286193T3 (da) | Indolderivater | |
| DK3288967T3 (da) | Farmaceutisk forbindelse |